February 18, 2021

The Efficacy and Safety of Favipiravir in Treatment of COVID-19 A Systematic Review and Meta-Analysis of Clinical Trials

Category: Article Summary

Topic: Testing and Treatment

Keywords (Tags): treatment

[Pre-print, not peer reviewed] A systematic review and meta-analysis of nine clinical trials found the antiviral medication favipiravir was associated with a significant clinical improvement (vs control) 7 days after hospital admission (RR=1.24). Risk of viral clearance by 14 days of hospital admission was higher while requirements for supplemental oxygen therapy and mortality were lower among individuals who received Favipiravir; however, these outcomes were not statistically significantly different than controls.

Hassanpour et al. (Feb 17, 2021). The Efficacy and Safety of Favipiravir in Treatment of COVID-19 A Systematic Review and Meta-Analysis of Clinical Trials. Pre-print downloaded Feb 18 from https://doi.org/10.1101/2021.02.14.21251693